RetinalGenix Technologies (RTGN) Accumulated Expenses (2021 - 2026)

RetinalGenix Technologies has disclosed Accumulated Expenses across 6 years of filings, most recently posting $20239.0 for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $20239.0, up 23.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $20239.0 (up 23.42% YoY), and the FY2025 annual result was $19279.0, up 24.87% from the prior year.
• Accumulated Expenses came in at $20239.0 for Q1 2026 at RetinalGenix Technologies, up from $19279.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $20239.0 in Q1 2026 to a low of $4079.0 in Q1 2022.
• The 5-year median for Accumulated Expenses is $12559.0 (2024), against an average of $12494.3.
• Across the five-year window, Accumulated Expenses soared 476.19% in 2022 and rose 23.42% in 2026, its largest moves.
• RetinalGenix Technologies' Accumulated Expenses stood at $7759.0 in 2022, then surged by 49.49% to $11599.0 in 2023, then soared by 33.11% to $15439.0 in 2024, then climbed by 24.87% to $19279.0 in 2025, then climbed by 4.98% to $20239.0 in 2026.
• The last three Accumulated Expenses figures came in at $20239.0 (Q1 2026), $19279.0 (Q4 2025), and $18319.0 (Q3 2025), per Business Quant data.